Shares in the £800m (€1.3bn) rights issue from Imperial Chemical Industries (ICI), the UK chemical firm, are likely to be priced at a 50% discount at 175p each, analysts said.

UBS Warburg is the lead adviser and broker of the issue, alongside Goldman Sachs as joint adviser and Merrill Lynch as joint broker.